Nath Bio-Genes (India) Q2 FY27: PAT ₹327 Cr & Rev ₹3,228 Cr

Metric	Value
Revenue	₹3,228 Cr
Net Profit (PAT)	₹327 Cr

📢 Key Event
Nath Bio-Genes reported 15% YoY revenue growth to ₹3,228 million in Q1FY27.

🔄 What Changed
Revenue grew 15% YoY to ₹3,228 million; EBITDA increased 17% to ₹351 million; gross profit rose 13% to ₹1,629 million.

🔮 What's Next
Nath Bio-Genes will focus on expanding its product basket, strengthening supply chain networks, and prioritizing disease-resistant seed development to drive future productivity and shareholder value.

💡 Investor Takeaway
The company is executing a growth strategy centered on premium product development and operational efficiency, leading to strong margin expansion and revenue growth.

Nath Bio-Genes reported a 15% YoY revenue increase to ₹3,228 million in Q1FY27, driven by strong growth in maize (44% volume) and paddy (19% volume), with cotton maintaining stable performance. Gross profit rose 13% to ₹1,629 million, and EBITDA surged 17% to ₹351 million, reflecting improved margins and operational efficiency. The company highlighted its diversified product portfolio, R&D investments, and expanding market reach across 23 states as key growth enablers.

📄 View Original Announcement (PDF)

📊 Stock Analysis — NATHBIOGEN ✨ Ask AI About This

About Nath Bio-Genes (India) Limited (NATHBIOGEN)

Fast Moving Consumer Goods · FMCG · Listed on NSE

Market Cap: ₹300.36 Cr P/E: 8.1 ROE: 6.0% ROCE: 7.9% Div Yield: 1.27%

View full NATHBIOGEN stock details →

📡 Get AI alerts when NATHBIOGEN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NATHBIOGEN — Free

💡 Ask AI about this filing

"What is the projected revenue growth rate for FY27?" "How does the company's EBITDA margin compare to industry peers?" "What is the expected impact of new product launches on future margins?"

Ask AI Free →

📊 More NATHBIOGEN filings

See all NATHBIOGEN filings →

🔥 Also filed on 30 July 2026

PARADEEP Paradeep Phosphates Limited Financial Results SYRMA Syrma SGS Technology Limited Offer Document AYMSYNTEX AYM Syntex Limited Announcement AJANTPHARM Ajanta Pharma Limited Corporate Action GATEWAY Gateway Distriparks Limited Corporate Action GILLETTE Gillette India Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NATHBIOGEN files new disclosures

Track NATHBIOGEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NATHBIOGEN — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd